Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) posted Treasury Shares of $18786.0 for Q4 2025, little changed on a QoQ basis from $18786.0 in Q4 2024, and little changed year-over-year from $18786.0 in Q4 2024.
Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018 - 2025) Analysis & Trends
Arcturus Therapeutics Holdings' Treasury Shares history runs 4 years deep, the most recent figure standing at $18786.0 for Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $18786.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18786.0 (changed 0.0% YoY) and the FY2025 annual result came in at $18786.0, changed 0.0% from the prior year.
- Treasury Shares was $18786.0 for Q4 2025 at Arcturus Therapeutics Holdings, roughly flat from $18786.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $18786.0 in Q4 2023 and bottomed at $18786.0 in Q4 2023.
- A 3-year average of $18786.0 and a median of $18786.0 in 2023 frame the typical range for Treasury Shares.
- Peak annual rise in Treasury Shares reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
- Arcturus Therapeutics Holdings' Treasury Shares stood at $18786.0 in 2023, then changed by 0.0% to $18786.0 in 2024, then changed by 0.0% to $18786.0 in 2025.
- Business Quant data shows ARCT's Treasury Shares at $18786.0 in Q4 2025, $18786.0 in Q4 2024, and $18786.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,786.00 |
| Dec 31, 2025 | 18,786.00 |
| Dec 31, 2024 | 18,786.00 |
| Dec 31, 2024 | 18,786.00 |
| Dec 31, 2023 | 18,786.00 |
| Dec 31, 2023 | 18,786.00 |
| Dec 31, 2018 | 43,000.00 |
| Dec 31, 2018 | 43,000.00 |